Literature DB >> 29995195

Visual function and inner retinal structure correlations in aquaporin-4 antibody-positive optic neuritis.

Nattapong Mekhasingharak1, Niphon Chirapapaisan2, Poramaet Laowanapiban3, Sasitorn Siritho4,5, Naraporn Prayoonwiwat4, Chanjira Satukijchai4,6, Jiraporn Jitprapaikulsan4, Pornsawan Mekhasingharak4.   

Abstract

PURPOSE: To investigate the correlation between visual function and thinning of the retinal nerve fiber layer (RNFL) and the macular ganglion cell-inner plexiform layer (GCIPL) as measured by optical coherence tomography (OCT) in eyes with aquaporin-4 IgG-positive optic neuritis (AQP4-IgG-positive ON). STUDY
DESIGN: Prospective study.
METHODS: Patients with a history of ON were categorized into 2 groups: the AQP4-IgG-positive group and the AQP4-IgG-negative group. Patients with multiple sclerosis were excluded. All patients underwent ophthalmologic examination and OCT imaging at least 6 months after the last episode of acute ON. Visual function and inner retinal structure correlations were analyzed using Pearson correlation and regression analyses.
RESULTS: Thirty-one previous ON eyes of 17 AQP4-IgG-positive patients and 21 previous ON eyes of 15 AQP4-IgG-negative patients were registered. Visual function, especially the visual field, was better correlated with RNFL than with macular GCIPL. The best correlation between visual function and RNFL was the linear model, whereas the best correlation between visual function and GCIPL was the nonlinear model (inverse regression). Regression models revealed worse visual function in AQP4-IgG-positive ON than in AQP4-IgG-negative ON, whereas no differences in RNFL and GCIPL were found between the 2 groups.
CONCLUSIONS: RNFL measured by OCT can be a useful retinal structure for estimating and monitoring visual field loss in AQP4-IgG-positive ON patients, particularly in patients whose visual field cannot be quantitated. The correlation between visual function and the inner retinal structure of eyes with AQP4-IgG is unique and differs from that of eyes without AQP4-IgG.

Entities:  

Keywords:  Aquaporin-4 antibody; Neuromyelitis optica; Optic neuritis; Optical coherence tomography; Visual function

Mesh:

Substances:

Year:  2018        PMID: 29995195     DOI: 10.1007/s10384-018-0607-4

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  23 in total

Review 1.  Spectral domain optical coherence tomography in the diagnosis and management of glaucoma.

Authors:  Ahmad A Aref; Donald L Budenz
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2010 Nov-Dec

2.  A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis.

Authors:  Olivier Outteryck; Bilal Majed; Sabine Defoort-Dhellemmes; Patrick Vermersch; Hélène Zéphir
Journal:  Mult Scler       Date:  2015-03-31       Impact factor: 6.312

3.  Relationship between visual field changes and optical coherence tomography measurements in advanced open-angle glaucoma.

Authors:  Snezhina S Kostianeva; Marieta I Konareva-Kostianeva; Marin A Atanassov
Journal:  Folia Med (Plovdiv)       Date:  2016-09-01

4.  Evaluation of the Macular Ganglion Cell-Inner Plexiform Layer and the Circumpapillary Retinal Nerve Fiber Layer in Early to Severe Stages of Glaucoma: Correlation with Central Visual Function and Visual Field Indexes.

Authors:  Maria Pilar Bambo; Noemi Güerri; Blanca Ferrandez; Beatriz Cameo; Isabel Fuertes; Vicente Polo; Elena Garcia-Martin
Journal:  Ophthalmic Res       Date:  2017-01-10       Impact factor: 2.892

5.  Comparative study of retinal nerve fiber layer measurement by StratusOCT and GDx VCC, II: structure/function regression analysis in glaucoma.

Authors:  Christopher Kai-shun Leung; Kelvin Kam-Long Chong; Wai-man Chan; Cedric Ka-Fai Yiu; Man-yee Tso; Jackson Woo; Moon-Kwong Tsang; Kwok-kay Tse; Wing-ho Yung
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799

6.  Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis.

Authors:  N Evangelou; D Konz; M M Esiri; S Smith; J Palace; P M Matthews
Journal:  Brain       Date:  2001-09       Impact factor: 13.501

7.  Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica.

Authors:  Masahiko Nakamura; Toru Nakazawa; Hiroshi Doi; Takehiro Hariya; Kazuko Omodaka; Tatsuro Misu; Toshiyuki Takahashi; Kazuo Fujihara; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-19       Impact factor: 3.117

8.  Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica.

Authors:  Harold Merle; Stéphane Olindo; Angélique Donnio; Raymond Richer; Didier Smadja; Philippe Cabre
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07-09       Impact factor: 4.799

9.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

10.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

View more
  1 in total

1.  Structure-function correlates of vision loss in neuromyelitis optica spectrum disorders.

Authors:  Alexander U Brandt; Hanna G Zimmermann; Norman K Gigengack; Frederike C Oertel; Seyedamirhosein Motamedi; Charlotte Bereuter; Ankelien Duchow; Rebekka Rust; Judith Bellmann-Strobl; Klemens Ruprecht; Tanja Schmitz-Hübsch; Friedemann Paul
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.